ClinicalTrials.Veeva

Menu

The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity on Diabetic Patients

A

Assiut University

Status

Not yet enrolling

Conditions

Diabetes Mellitus
Rheumatoid Arthritis (RA

Study type

Observational

Funder types

Other

Identifiers

NCT06691997
DM and Rheumatoid Arthritis

Details and patient eligibility

About

The incidence of DM is unclear in RA but most prior data suggest that DM or insulin resistance in RA has risen because of activation of the immune system and/or RA therapy .

Besides, RA causes joints to become stiff, swollen, and agonizing. As a result, the patient may not want to exercise or move. One study found that 42% of people with RA are not physically active. the aim of this study is To evaluate the glycemic status among RA patients with Type 2 diabetes and its association with disease activity.

Full description

Taking the potential link between DM and RA into consideration, detection and control of DM will significantly increase prolonged prognosis and therefore decrease the economic burden of RA patients and death rate. The aim of this research is to examine diabetic RA's glycemic status and to assess the relationship between RA and DM's clinical characteristics as well as the therapy response in RA patients with diagnosed DM. Keeping an eye on glycemic control in RA patients could prevent metabolic and cardiovascular comorbidities in those susceptible patients.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • type 2 diabetic patients
  • rheumatoid arthritis patients

Exclusion criteria

  • gestional diabetes
  • type 1 diabetic patients

Trial design

100 participants in 1 patient group

group 1
Description:
RA patients with Type 2 diabetes

Trial contacts and locations

1

Loading...

Central trial contact

Eman Mohamed Ibrahim, Lecturer; Ahmed khedr Nady

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems